Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 44 84.09 85.75 1.18 0.47 2.42 0.771 64 85.94 87.22 1.15 0.53 2.18 Baptist Medical Center, Little Rock (ARBH) 9 55.56 85.18 4.16 1.13 Arkansas Childrens Hospital, Little Rock (ARCH) 4 50.00 68.35 1.59 The University Hospital of Arkansas, Little Rock (ARUA) 8 75.00 87.47 - - Cedars Sinai Medical Center, Los Angeles (CACS) 74 Loma Linda University Medical Center, Loma Linda (CALL) 13 State and Center U.S. 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.2 365 0.768 Not Significantly Different (a) 98.8 365 10.66 0.033 Statistically Lower (b) 98.7 365 0.19 5.75 0.715 Not Significantly Different (a) 100.0 365 2.01 0.24 7.27 0.524 Not Significantly Different (a) 99.1 365 - - - - - - - 94.59 87.64 0.43 0.12 1.09 0.086 Not Significantly Different (a) 99.7 365 100.00 85.59 0.00 0.00 1.47 0.262 Not Significantly Different (a) 98.4 365 Alabama University of Alabama Hospital, Birmingham (ALUA) Arizona University Medical Center, Univ of Arizona, Tucson (AZUA) Arkansas California Childrens Hospital Los Angeles, Los Angeles (CACL) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 1 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA California Pacific Medical Center, San Francisco (CAPM) 22 90.91 87.01 0.67 0.08 2.42 0.854 University of California San Diego Medical Center, San Diego (CASD) 24 70.83 87.77 2.41 0.97 4.96 University of California San Francisco Medical Center, San Francisco (CASF) 9 77.78 88.20 1.83 0.22 Sutter Memorial Hospital, Sacramento (CASG) 8 100.00 93.32 0.00 Sharp Memorial Hospital, San Diego (CASH) 31 93.55 89.29 Stanford University Medical Center, Stanford (CASU) 95 85.26 St. Vincent Medical Center, Los Angeles (CASV) 27 State and Center U.S. University of California at Los Angeles Medical Center, Los Angeles (CAUC) University of Southern California University Hospital, Los Angeles (CAUH) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.9 365 0.058 Not Significantly Different (a) 99.8 365 6.62 0.595 Not Significantly Different (a) 98.9 365 0.00 5.42 0.999 Not Significantly Different (a) 99.3 365 0.61 0.07 2.19 0.719 Not Significantly Different (a) 99.1 365 84.91 0.98 0.54 1.64 0.999 Not Significantly Different (a) 99.3 365 74.07 82.99 1.90 0.76 3.91 0.162 Not Significantly Different (a) 95.0 365 184 89.67 84.95 0.64 0.39 1.01 0.053 Not Significantly Different (a) 81.6 365 28 89.29 86.03 0.74 0.15 2.17 0.849 Not Significantly Different (a) 96.0 365 3 100.00 82.10 0.00 0.00 4.91 0.999 Not Significantly Different (a) 100.0 365 Colorado The Children's Hospital, Denver (COCH) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 2 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 46 78.26 86.23 1.79 0.86 3.29 0.117 Hartford Hospital, Hartford (CTHH) 20 65.00 79.18 1.63 0.65 3.35 Yale New Haven Hospital, New Haven (CTYN) 28 78.57 83.97 1.28 0.47 - - - - 13 92.31 92.09 - - Jackson Memorial Hospital University of Miami School of Medicine, Miami (FLJM) 44 St. Lukes Hospital (Mayo Clinic), Jacksonville (FLSL) 19 State and Center U.S. University Hospital University of Colorado Health Science Center, Denver (COUC) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 100.0 365 0.289 Not Significantly Different (a) 99.7 365 2.79 0.657 Not Significantly Different (a) 95.5 365 - - - - - 1.01 0.03 5.64 0.999 99.3 365 - - - - - - - 90.91 88.46 0.78 0.21 1.99 0.831 Not Significantly Different (a) 97.5 365 94.74 87.78 0.43 0.01 2.42 0.660 Not Significantly Different (a) 99.5 365 Connecticut District of Columbia Childrens National Medical Center, Washington (DCCH) Washington Hospital Center, Washington (DCWH) - Not Significantly Different (a) Florida All Childrens Hospital, St. Petersburg (FLAC) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 3 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 129 89.15 87.71 0.88 0.48 1.48 0.765 7 57.14 82.50 3.07 0.63 8.97 55 92.73 87.06 0.53 0.14 2 100.00 84.99 0.00 Emory University Hospital, Atlanta (GAEM) 55 96.36 87.84 Saint Joseph's Hospital of Atlanta, Atlanta (GASJ) 12 83.33 4 1 State and Center U.S. Tampa General Hospital, Tampa (FLTG) Tallahassee Memorial Hospital, Tallahassee (FLTO) Shands Hospital at The University of Florida, Gainesville (FLUF) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.4 365 0.152 Not Significantly Different (a) 58.9 365 1.35 0.255 Not Significantly Different (a) 96.1 365 0.00 9.22 0.999 Not Significantly Different (a) 50.8 365 0.28 0.03 1.01 0.053 Not Significantly Different (a) 99.3 365 88.21 1.46 0.18 5.26 0.797 Not Significantly Different (a) 72.1 365 100.00 92.09 0.00 0.00 9.04 0.999 Not Significantly Different (a) 100.0 365 100.00 91.51 0.00 0.00 33.80 0.999 Not Significantly Different (a) 100.0 365 Georgia Children's Healthcare of Atlanta at Egleston, Atlanta (GAEH) Hawaii St Francis Medical Center, Honolulu (HISF) Illinois Children's Memorial Hospital, Chicago (ILCM) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 4 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 4,487 86.65 NA 1.00 NA NA 49 87.76 89.30 1.15 0.42 2.51 0.840 - - - - - - - Rush University Medical Center, Chicago (ILPL) 13 69.23 90.62 3.58 0.97 9.16 0.054 OSF Saint Francis Medical Center, Peoria (ILSF) 23 91.30 86.07 0.59 0.07 2.14 0.688 - - - - - - - 50 72.00 86.36 2.30 1.26 3.85 0.008 Statistically Lower (b) 7 71.43 88.66 3.14 0.38 11.35 0.268 33 93.94 87.20 0.43 0.05 1.57 0.322 - - - - - - - 30 80.00 88.31 1.91 0.70 4.15 0.199 U.S. Loyola University Medical Center, Maywood (ILLU) Northwestern Memorial Hospital, Chicago (ILNM) St. Johns Hospital, Springfield (ILSJ) University of Chicago Medical Center, Chicago (ILUC) University of Illinois Medical Center, Chicago (ILUI) 95% Confidence Interval 4 How do the rates at this center compare to those in the nation? Patient Survival (%) 2 State and Center Lower Bound Upper Bound P-value (2-sided) 5 NA Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 99.6 365 - - Not Significantly Different (a) 100.0 365 Not Significantly Different (a) 100.0 365 - - 99.5 365 Not Significantly Different (a) 100.0 365 Not Significantly Different (a) 94.8 365 - - 95.9 365 Not Significantly Different (a) - - Indiana Clarian Health/Methodist/Indiana U/Riley, Indianapolis (INIM) Indiana University Medical Center, Indianapolis (INIU) Lutheran Hospital of Fort Wayne, Ft Wayne (INLH) - Not Significantly Different (a) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 5 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart State and Center U.S. St Vincent Hospital and Health Care Center, Indianapolis (INSV) Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 95% Confidence Interval 4 4,487 86.65 NA 1.00 NA NA 27 81.48 87.94 1.56 0.51 3.64 0.442 21 95.24 89.21 0.42 0.01 2.34 0.624 - - - - - - - 5 60.00 88.53 6.08 0.74 21.95 0.087 51 88.24 86.54 0.90 0.33 1.96 0.999 - - - - - - - 27 85.19 89.16 1.42 0.39 3.64 0.622 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.7 365 Not Significantly Different (a) 99.0 365 - - Not Significantly Different (a) 99.0 365 Not Significantly Different (a) 97.6 365 - - 98.7 365 Iowa University of Iowa Hospitals and Clinics, Iowa City (IAIV) Iowa City VA Medical Center, Iowa City (IAIV) - Kansas Via Christi Regional Medical Center, St Francis Campus, Wichita (KSFW) Kentucky Jewish Hospital, Louisville (KYJH) Kosair Childrens Hospital, Louisville (KYKC) University of Kentucky Medical Center, Lexington (KYUK) - Not Significantly Different (a) Louisiana NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 6 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA Ochsner Foundation Hospital, New Orleans (LAOF) 66 87.88 86.98 0.95 0.41 1.88 0.999 Tulane University Medical Center, New Orleans (LATU) 26 88.46 88.02 1.00 0.21 2.93 Willis Knighton Medical Center, Shreveport (LAWK) 21 80.95 82.54 1.15 0.31 Johns Hopkins Hospital, Baltimore (MDJH) 36 77.78 89.25 2.30 University of Maryland Medical System, Baltimore (MDUM) 18 88.89 84.45 - - Massachusetts General Hospital, Boston (MAMG) 27 New England Medical Center, Boston (MANM) Brigham and Womens Hospital, Boston (MAPB) State and Center U.S. 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 97.0 365 0.999 Not Significantly Different (a) 99.3 365 2.94 0.919 Not Significantly Different (a) 99.9 365 0.99 4.53 0.052 Not Significantly Different (a) 94.8 365 0.70 0.08 2.51 0.904 Not Significantly Different (a) 92.3 365 - - - - - - - 92.59 88.44 0.67 0.08 2.42 0.852 Not Significantly Different (a) 100.0 365 37 89.19 88.15 0.95 0.26 2.43 0.999 Not Significantly Different (a) 100.0 365 40 90.00 86.49 0.75 0.20 1.91 0.763 Not Significantly Different (a) 99.6 365 Maryland Massachusetts Children's Hospital, Boston (MACH) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 7 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 5 80.00 86.43 1.65 0.04 9.20 0.908 - - - - - - - Henry Ford Hospital, Detroit (MIHF) 42 78.57 86.14 1.76 0.80 3.33 0.153 University of Michigan Medical Center, Ann Arbor (MIUM) 67 88.06 88.94 1.06 0.46 2.09 Abbott Northwestern Hospital, Minneapolis (MNAN) 14 100.00 90.24 0.00 0.00 Saint Marys Hospital (Mayo Clinic), Rochester (MNSM) 35 94.29 87.17 0.43 Fairview University Medical Center, Minneapolis (MNUM) 62 87.10 87.58 22 81.82 89.44 State and Center U.S. University of Massachusetts Memorial Medical Center, Worcester (MAUM) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 100.0 365 - - Not Significantly Different (a) 99.0 365 0.967 Not Significantly Different (a) 99.8 365 2.06 0.466 Not Significantly Different (a) 99.9 365 0.05 1.55 0.311 Not Significantly Different (a) 99.3 365 1.05 0.45 2.06 0.996 Not Significantly Different (a) 97.9 365 1.82 0.50 4.66 0.361 Not Significantly Different (a) 99.9 365 Not Significantly Different (a) Michigan Children's Hospital of Michigan, Detroit (MICH) - Minnesota Mississippi University of Mississippi Medical Center, Jackson (MSUM) Missouri NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 8 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 62 88.71 90.19 1.15 0.46 2.37 0.817 Cardinal Glennon Children's Hospital, St. Louis (MOCG) - - - - - - - St Louis Childrens Hospital at Washington University Medical Center, St Louis (MOCH) 4 50.00 82.20 5.20 0.63 18.79 0.115 St Lukes Hospital of Kansas City, Kansas City (MOLH) 30 90.00 89.39 0.90 0.19 2.64 St Louis University Hospital, St Louis (MOSL) 10 70.00 86.97 2.90 0.60 8 75.00 89.33 2.87 13 84.62 89.69 - - 70 90.00 State and Center U.S. Barnes-Jewish Hospital, St. Louis (MOBH) University of Missouri Hospital and Clinics, Columbia (MOUM) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 99.7 365 - - Not Significantly Different (a) 96.0 365 0.999 Not Significantly Different (a) 99.6 365 8.49 0.173 Not Significantly Different (a) 97.4 365 0.35 10.35 0.310 Not Significantly Different (a) 100.0 365 1.60 0.19 5.77 0.712 Not Significantly Different (a) 97.3 365 - - - - - - - 86.18 0.67 0.27 1.38 0.370 94.9 365 Not Significantly Different (a) - Nebraska BryanLGH Medical Center East, Lincoln (NEBM) Nebraska Medical Center, Omaha (NEUN) - New Jersey Newark Beth Israel Medical Center, Newark (NJBI) Not Significantly Different (a) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 9 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 18 100.00 83.30 0.00 0.00 0.87 0.064 1 100.00 94.41 0.00 0.00 52.17 62 87.10 83.22 0.74 0.32 - - - - 185 85.95 84.49 Strong Memorial Hospital, University of Rochester Medical Center, Rochester (NYFL) 28 89.29 Montefiore Medical Center, Bronx (NYMA) 22 Mount Sinai Medical Center, New York (NYMS) Westchester Medical Center, Valhalla (NYWC) State and Center U.S. Robert Wood Johnson University Hospital, New Brunswick (NJRW) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 95.4 365 0.999 Not Significantly Different (a) 11.0 365 1.45 0.494 Not Significantly Different (a) 99.3 365 - - - - - 0.90 0.59 1.32 0.689 Not Significantly Different (a) 93.2 365 84.94 0.67 0.14 1.95 0.682 Not Significantly Different (a) 100.0 365 81.82 84.95 1.21 0.33 3.09 0.847 Not Significantly Different (a) 99.5 365 47 85.11 81.52 0.79 0.32 1.63 0.688 Not Significantly Different (a) 99.8 365 11 63.64 82.55 3.27 0.89 8.37 0.072 Not Significantly Different (a) 98.7 365 New Mexico Presbyterian Hospital, Albuquerque (NMPH) New York Albany Medical Center Hospital, Albany (NYAM) Buffalo General Hospital/ Children's Hospital, Buffalo (NYBU) The Presbyterian Hosp in NY City, New York (NYCP) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 10 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 9 55.56 80.36 2.27 0.62 5.80 0.206 38 92.11 89.31 0.74 0.15 2.17 Duke University Medical Center, Durham (NCDU) 146 89.04 85.44 0.71 0.40 University of North Carolina Hospitals, Chapel Hill (NCMH) 31 90.32 87.82 0.78 151 93.38 86.71 Children's Hospital, Columbus (OHCH) - - Children's Hospital Medical Center, Cincinnati (OHCM) 1 Medical College Hospitals, Toledo (OHCO) State and Center 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.8 365 0.849 Not Significantly Different (a) 97.7 365 1.15 0.190 Not Significantly Different (a) 97.0 365 0.16 2.27 0.920 Not Significantly Different (a) 97.6 365 0.47 0.23 0.87 0.011 Statistically Higher (b) 91.1 365 - - - - - - - 100.00 90.23 0.00 0.00 29.17 0.999 Not Significantly Different (a) 100.0 365 14 78.57 83.51 1.24 0.26 3.62 0.871 Not Significantly Different (a) 99.5 365 Ohio State University Hospital, Columbus (OHOU) 21 80.95 88.61 1.68 0.46 4.30 0.436 Not Significantly Different (a) 99.5 365 University of Cincinnati Medical Center/ University Hospital, Cincinnati (OHUC) 23 73.91 84.37 1.75 0.64 3.81 0.267 Not Significantly Different (a) 97.2 365 U.S. North Carolina North Carolina Baptist Hospital, Winston Salem (NCBG) Carolinas Medical Center, Charlotte (NCCM) Ohio The Cleveland Clinic Foundation, Cleveland (OHCC) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 11 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Follow-up days reported by center (%) Transplants (n) 1 4,487 86.65 NA 1.00 NA NA 16 62.50 87.08 3.35 1.23 7.30 0.020 Statistically Lower (b) 37 89.19 88.30 0.86 0.23 2.21 0.999 Not Significantly Different (a) - - - - - - - 23 78.26 90.28 2.49 0.81 5.80 0.107 Providence Portland Medical Center, Portland (ORPM) 13 92.31 89.73 0.70 0.02 3.88 Oregon Health Sciences, Portland (ORUO) 52 92.31 88.09 0.62 0.17 13 84.62 83.51 1.01 Children's Hospital of Pittsburgh, Pittsburgh (PACH) 1 0.00 62.54 Children's Hospital of Philadelphia, Philadelphia (PACP) 2 0.00 81.48 U.S. University Hospitals of Cleveland, Cleveland (OHUH) 95% Confidence Interval 4 How do the rates at this center compare to those in the nation? Patient Survival (%) 2 State and Center Lower Bound Upper Bound P-value (2-sided) 5 NA NA 6 Maximum Days of Follow-up (n) 97.1 365 100.0 365 99.6 365 - - Not Significantly Different (a) 99.7 365 0.999 Not Significantly Different (a) 97.3 365 1.59 0.457 Not Significantly Different (a) 99.9 365 0.12 3.64 0.999 Not Significantly Different (a) 83.1 365 8.43 0.21 46.98 0.224 Not Significantly Different (a) 100.0 10 22.94 2.78 82.88 0.007 Statistically Lower (b) 100.0 20 Oklahoma Integris Baptist Medical Center, Oklahoma City (OKBC) OU Medical Center, Oklahoma City (OKMD) Saint Francis Hospital, Tulsa (OKSF) - Oregon Pennsylvania Allegheny General Hospital, Pittsburgh (PAAG) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 12 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA Penn State Milton S Hershey Medical Center, Hershey (PAHE) 34 76.47 85.81 1.78 0.77 3.51 0.172 Hahnemann University Hospital Tenet, Philadelphia (PAHM) 39 79.49 81.05 1.03 0.44 2.02 University of Pittsburgh Medical Center, Pittsburgh (PAPT) 84 83.33 83.43 1.00 0.55 Temple University Hospital, Philadelphia (PATU) 92 78.26 83.29 1.40 120 87.50 85.90 23 100.00 45 35 State and Center U.S. Hospital of the University of Pennsylvania, Philadelphia (PAUP) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.0 365 0.999 Not Significantly Different (a) 99.2 365 1.69 0.999 Not Significantly Different (a) 99.1 365 0.85 2.16 0.180 Not Significantly Different (a) 99.6 365 0.89 0.50 1.47 0.775 Not Significantly Different (a) 98.7 365 91.07 0.00 0.00 1.38 0.229 Not Significantly Different (a) 98.8 365 97.78 89.08 0.20 0.01 1.12 0.082 Not Significantly Different (a) 99.7 365 91.43 88.58 0.72 0.15 2.12 0.813 Not Significantly Different (a) 99.9 365 Puerto Rico Cardiovascular Center of Puerto Rico and the Caribbean, San Juan (PRCC) South Carolina Medical University of South Carolina, Charleston (SCMU) Tennessee Baptist Memorial Hospital, Memphis (TNBM) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 13 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA Saint Thomas Hospital, Nashville (TNST) 35 91.43 85.77 0.57 0.12 1.66 0.453 Vanderbilt University Medical Center, Nashville (TNVU) 57 77.19 87.31 1.99 1.06 3.40 Brooke Army Medical Center, Fort Sam Houston (TXBA) 1 100.00 89.34 0.00 0.00 University Hospital University of Texas Health Science Center, San Antonio (TXBC) - - - - Children's Medical Center of Dallas, Dallas (TXCM) 2 100.00 83.98 Seton Medical Center, Austin (TXCT) 37 89.19 Columbia Hospital at Medical City Dallas, Dallas (TXHD) 43 St Lukes Episcopal Hospital, Houston (TXHI) State and Center 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.8 365 0.034 Statistically Lower (b) 99.6 365 26.62 0.999 Not Significantly Different (a) 100.0 365 - - - - - 0.00 0.00 8.58 0.999 Not Significantly Different (a) 100.0 365 88.29 1.01 0.27 2.58 0.999 Not Significantly Different (a) 100.0 365 93.02 88.62 0.61 0.12 1.77 0.544 Not Significantly Different (a) 100.0 365 70 77.14 86.62 1.89 1.08 3.07 0.027 Statistically Lower (b) 94.9 365 Methodist Specialty & Transplant Hospital, San Antonio (TXHS) 44 79.55 85.29 1.43 0.66 2.72 0.367 Not Significantly Different (a) 93.9 365 University of Texas Medical Branch at Galveston, Galveston (TXJS) 14 78.57 83.28 1.23 0.25 3.61 0.876 Not Significantly Different (a) 96.5 365 U.S. Texas - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 14 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA The Methodist Hospital Baylor College of Medicine, Houston (TXMH) 68 80.88 88.65 1.82 0.97 3.10 0.063 Christus Santa Rosa Medical Center, San Antonio (TXRM) 26 76.92 88.15 2.11 0.78 4.60 St Paul University Hospital, Dallas (TXSP) 43 93.02 86.11 0.48 0.10 - - - - 34 88.24 86.35 LDS Hospital, Salt Lake City (UTLD) 36 94.44 University of Utah Medical Center, Salt Lake City (UTMC) 36 State and Center U.S. Texas Children's Hospital, Houston (TXTC) Baylor University Medical Center, Dallas (TXTX) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 96.7 365 0.137 Not Significantly Different (a) 85.0 365 1.40 0.255 Not Significantly Different (a) 99.2 365 - - - - - 0.80 0.22 2.05 0.883 Not Significantly Different (a) 99.6 365 88.78 0.49 0.06 1.77 0.456 Not Significantly Different (a) 94.9 365 91.67 86.86 0.60 0.12 1.76 0.535 Not Significantly Different (a) 96.7 365 2 100.00 80.14 0.00 0.00 6.76 0.999 Not Significantly Different (a) 100.0 365 32 93.75 90.62 0.65 0.08 2.36 0.819 Not Significantly Different (a) 99.4 365 - Utah Primary Childrens Medical Center, Salt Lake City (UTPC) Virginia Inova Fairfax Hospital, Falls Church (VAFH) NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 15 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA Henrico Doctors Hospital, Richmond (VAHD) 11 81.82 88.88 1.67 0.20 6.02 0.674 Medical College of Virginia Hospitals, Richmond (VAMC) 12 58.33 85.63 3.75 1.22 8.76 Hunter Holmes McGuire Veterans Administration Medical Center, Richmond (VAMV) 16 81.25 83.66 1.48 0.31 Sentara Norfolk General Hospital, Norfolk (VANG) 40 90.00 86.47 0.72 University of Virginia Health Sciences Center, Charlottesville (VAUV) 30 90.00 86.65 - - Sacred Heart Medical Center, Spokane (WASH) 22 University of Washington Medical Center, Seattle (WAUW) State and Center U.S. 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 100.0 365 0.023 Statistically Lower (b) 100.0 365 4.33 0.661 Not Significantly Different (a) 99.4 365 0.20 1.85 0.707 Not Significantly Different (a) 99.6 365 0.76 0.16 2.21 0.883 Not Significantly Different (a) 97.8 365 - - - - - - - 95.45 89.17 0.40 0.01 2.23 0.577 Not Significantly Different (a) 100.0 365 68 95.59 86.00 0.30 0.06 0.88 0.021 Statistically Higher (b) 99.9 365 - - - - - - - - - Washington Childrens Hospital Medical Center, Seattle (WACH) - Wisconsin Children's Hospital of Wisconsin, Milwaukee (WICH) - NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 16 Center Specific Report Table 11 Summary: 1 Year Patient Survival, Adult For Patients Transplanted between 01/01/2001 - 06/30/2003 Organ: HR: Heart Expected Patient Survival (%) 3 Ratio of Observed to Expected Failures Transplants (n) 1 Patient Survival (%) 2 4,487 86.65 NA 1.00 NA NA 7 57.14 88.60 4.71 0.97 13.75 0.054 St. Luke's Medical Center, Milwaukee (WISL) 84 89.29 89.03 0.96 0.44 1.83 University of Wisconsin Hospital and Clinics, Madison (WIUW) 47 95.74 85.89 0.31 0.04 1.12 State and Center U.S. Froedtert Memorial Lutheran Hospital, Milwaukee (WISE) 95% Confidence Interval 4 Lower Bound Upper Bound P-value (2-sided) 5 NA How do the rates at this center compare to those in the nation? Follow-up days reported by center (%) NA 6 Maximum Days of Follow-up (n) 97.1 365 Not Significantly Different (a) 99.6 365 0.999 Not Significantly Different (a) 99.4 365 0.090 Not Significantly Different (a) 99.7 365 NA=Not Applicable. 1 Transplants during the time period indicated in the last row of the table. 2 Because different cohorts are followed for each time period, it is possible for reported 3-year survival to exceed 1-year survival. 3 Based on U.S. patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. 4 The 95% confidence interval gives a range of values for the true ratio of deaths at the facility to those expected based on the national experience. The true ratio will be between this lower and upper bound 95% of the time. 5 A p-value less than or equal to 0.05 indicates that the difference between the actual and expected patient survival is probably real and is not due to random chance, while a p-value greater than 0.05 indicates that the difference could possibly be due to random chance. (a) This difference could plausibly be just a chance occurrence. (b) This difference is unlikely due to random chance and probably represents a real difference from the expected survival. 6 Of days expected to be included in the follow-up period, the percentage of days covered by follow-up reporting by all centers for these tranplants. Additional follow-up days included in survival may be covered by SSDMF data. This measures the possibility that events such as failure have occurred without being reported, and it is not a measure of compliance. Based on data available as of 10/31/2004. Release at www.ustransplant.org on 01/11/2005. 17